MB Financial Bank - Trust Department’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-5
Closed -$4K 419
2017
Q1
$4K Hold
5
﹤0.01% 388
2016
Q4
$5K Hold
5
﹤0.01% 337
2016
Q3
$9K Hold
5
﹤0.01% 267
2016
Q2
$8K Hold
5
﹤0.01% 265
2016
Q1
$8K Hold
5
﹤0.01% 296
2015
Q4
$8K Hold
5
﹤0.01% 331
2015
Q3
$8K Hold
5
﹤0.01% 388
2015
Q2
$13K Hold
5
﹤0.01% 360
2015
Q1
$13K Hold
5
﹤0.01% 336
2014
Q4
$12K Sell
5
-4
-44% -$10.3K ﹤0.01% 367
2014
Q3
$29K Buy
9
+4
+80% +$13K ﹤0.01% 427
2014
Q2
$16K Hold
5
﹤0.01% 408
2014
Q1
$17K Hold
5
﹤0.01% 329
2013
Q4
$18K Hold
5
﹤0.01% 327
2013
Q3
$15K Hold
5
﹤0.01% 334
2013
Q2
$12K Buy
+5
New +$12.4K ﹤0.01% 324

Other funds holding TRIB

MB Financial Bank - Trust Department's TRIB Position: Q2 2017 in Review

MB Financial Bank - Trust Department sold out of Trinity Biotech (TRIB) in Q2 2017, closing a stake of 5 shares — an estimated $4K sold.

MB Financial Bank - Trust Department first reported a position in TRIB in Q2 2013 and held it in 16 quarters. The position peaked at $29K in Q3 2014. 56 funds tracked by Wall St. Rank hold TRIB as of Q2 2017.

  • MB Financial Bank - Trust Department reported no remaining Trinity Biotech position as of Q2 2017 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 5 Trinity Biotech shares in Q2 2017, an estimated $4K.
  • MB Financial Bank - Trust Department first reported a position in Trinity Biotech in Q2 2013 and held it in 16 quarters.
  • MB Financial Bank - Trust Department's Trinity Biotech position peaked at $29K in Q3 2014.
  • 56 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2017.

Based on MB Financial Bank - Trust Department's 13F filing for Q2 2017, filed 12 Jul 2017.